Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 612798, 11 pages
http://dx.doi.org/10.1155/2014/612798
Review Article

NF- B Mediated Regulation of Adult Hippocampal Neurogenesis: Relevance to Mood Disorders and Antidepressant Activity

Laboratory of Neuroplasticity, Department of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy

Received 15 November 2013; Accepted 28 December 2013; Published 12 February 2014

Academic Editor: Catia M. Teixéira

Copyright © 2014 Valeria Bortolotto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Kempermann and F. H. Gage, “New nerve cells for the adult brain,” Scientific American, vol. 280, no. 5, pp. 48–53, 1999. View at Google Scholar · View at Scopus
  2. C. G. Gross, “Neurogenesis in the adult brain: death of a dogma,” Nature Reviews, vol. 1, no. 1, pp. 67–73, 2000. View at Google Scholar · View at Scopus
  3. D. C. Lie, H. Song, S. A. Colamarino, G.-L. Ming, and F. H. Gage, “Neurogenesis in the adult brain: new strategies for central nervous system diseases,” Annual Review of Pharmacology and Toxicology, vol. 44, pp. 399–421, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Kempermann, S. Jessberger, B. Steiner, and G. Kronenberg, “Milestones of neuronal development in the adult hippocampus,” Trends in Neurosciences, vol. 27, no. 8, pp. 447–452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Seri, J. M. García-Verdugo, L. Collado-Morente, B. S. McEwen, and A. Alvarez-Buylla, “Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus,” Journal of Comparative Neurology, vol. 478, no. 4, pp. 359–378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G.-L. Ming and H. Song, “Adult neurogenesis in the mammalian central nervous system,” Annual Review of Neuroscience, vol. 28, pp. 223–250, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Biebl, C. M. Cooper, J. Winkler, and H. G. Kuhn, “Analysis of neurogenesis and programmed cell death reveals a self- renewing capacity in the adult rat brain,” Neuroscience Letters, vol. 291, no. 1, pp. 17–20, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Lehmann, M. Butz, and G. Teuchert-Noodt, “Offer and demand: proliferation and survival of neurons in the dentate gyrus,” European Journal of Neuroscience, vol. 21, no. 12, pp. 3205–3216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. J. Shors, G. Miesegaes, A. Beylin, M. Zhao, T. Rydel, and E. Gould, “Neurogenesis in the adult is involved in the formation of trace memories,” Nature, vol. 410, no. 6826, pp. 372–376, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Brown, C. M. Cooper-Kuhn, G. Kempermann et al., “Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis,” European Journal of Neuroscience, vol. 17, no. 10, pp. 2042–2046, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Bruel-Jungerman, S. Laroche, and C. Rampon, “New neurons in the dentate gyrus are involved in the expression of enhanced long-term memory following environmental enrichment,” European Journal of Neuroscience, vol. 21, no. 2, pp. 513–521, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ueda, S. Sakakibara, and K. Yoshimoto, “Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learning,” Neuroscience, vol. 135, no. 2, pp. 395–402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Leal-Galicia, M. Castañeda-Bueno, R. Quiroz-Baez, and C. Arias, “Long-term exposure to environmental enrichment since youth prevents recognition memory decline and increases synaptic plasticity markers in aging,” Neurobiology of Learning and Memory, vol. 90, no. 3, pp. 511–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Gould, B. S. McEwen, P. Tanapat, L. A. M. Galea, and E. Fuchs, “Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation,” Journal of Neuroscience, vol. 17, no. 7, pp. 2492–2498, 1997. View at Google Scholar · View at Scopus
  15. V. Lemaire, M. Koehl, M. Le Moal, and D. N. Abrous, “Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 20, pp. 11032–11037, 2000. View at Google Scholar · View at Scopus
  16. C. L. Coe, M. Kramer, B. Czéh et al., “Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile Rhesus monkeys,” Biological Psychiatry, vol. 54, no. 10, pp. 1025–1034, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Simon, B. Czéh, and E. Fuchs, “Age-dependent susceptibility of adult hippocampal cell proliferation to chronic psychosocial stress,” Brain Research, vol. 1049, no. 2, pp. 244–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Thomas, G. Hotsenpiller, and D. A. Peterson, “Acute psychosocial stress reduces cell survival in adult hippocampal neurogenesis without altering proliferation,” Journal of Neuroscience, vol. 27, no. 11, pp. 2734–2743, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Klempin and G. Kempermann, “Adult hippocampal neurogenesis and aging,” European Archives of Psychiatry and Clinical Neuroscience, vol. 257, no. 5, pp. 271–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. H. G. Kuhn, T. D. Palmer, and E. Fuchs, “Adult neurogenesis: a compensatory mechanism for neuronal damage,” European Archives of Psychiatry and Clinical Neuroscience, vol. 251, no. 4, pp. 152–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Conti, T. Cataudella, and E. Cattaneo, “Neural stem cells: a pharmacological tool for brain diseases?” Pharmacological Research, vol. 47, no. 4, pp. 289–297, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Steiner, S. Wolf, and G. Kempermann, “Adult neurogenesis and neurodegenerative disease,” Regenerative medicine, vol. 1, no. 1, pp. 15–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Eisch, H. A. Cameron, J. M. Encinas, L. A. Meltzer, G.-L. Ming, and L. S. Overstreet-Wadiche, “Adult neurogenesis, mental health, and mental illness: hope or hype?” Journal of Neuroscience, vol. 28, no. 46, pp. 11785–11791, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Kempermann, J. Krebs, and K. Fabel, “The contribution of failing adult hippocampal neurogenesis to psychiatric disorders,” Current Opinion in Psychiatry, vol. 21, no. 3, pp. 290–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. N. A. DeCarolis and A. J. Eisch, “Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation,” Neuropharmacology, vol. 58, no. 6, pp. 884–893, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Duman, S. Nakagawa, and J. Malberg, “Regulation of adult neurogenesis by antidepressant treatment,” Neuropsychopharmacology, vol. 25, no. 6, pp. 836–844, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. R. S. Duman, J. Malberg, and S. Nakagawa, “Regulation of adult neurogenesis by psychotropic drugs and stress,” Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 2, pp. 401–407, 2001. View at Google Scholar · View at Scopus
  28. C. G. Wakade, S. P. Mahadik, J. L. Waller, and F.-C. Chiu, “Atypical neuroleptics stimulate neurogenesis in adult rat brain,” Journal of Neuroscience Research, vol. 69, no. 1, pp. 72–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. Harwood, “Neurodevelopment and mood stabilizers,” Current Molecular Medicine, vol. 3, no. 5, pp. 472–482, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. E. Malberg, “Implications of adult hippocampal neurogenesis in antidepressant action,” Journal of Psychiatry and Neuroscience, vol. 29, no. 3, pp. 196–205, 2004. View at Google Scholar · View at Scopus
  31. A. J. Eisch, M. Barrot, C. A. Schad, D. W. Self, and E. J. Nestler, “Opiates inhibit neurogenesis in the adult rat hippocampus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 13, pp. 7579–7584, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. F. T. Crews and K. Nixon, “Alcohol, neural stem cells, and adult neurogenesis,” Alcohol Research and Health, vol. 27, no. 2, pp. 197–204, 2003. View at Google Scholar · View at Scopus
  33. J. J. Canales, “Adult neurogenesis and the memories of drug addiction,” European Archives of Psychiatry and Clinical Neuroscience, vol. 257, no. 5, pp. 261–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Sen and D. Baltimore, “Inducibility of K immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism,” Cell, vol. 47, no. 6, pp. 921–928, 1986. View at Google Scholar · View at Scopus
  35. T. Krakauer, “Nuclear factor-κB: fine-tuning a central integrator of diverse biologic stimuli,” International Reviews of Immunology, vol. 27, no. 5, pp. 286–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Gerondakis, R. Grumont, R. Gugasyan et al., “Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models,” Oncogene, vol. 25, no. 51, pp. 6781–6799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Grilli, J. J.-S. Chiu, and M. J. Lenardo, “NF-κB and Rel: participants in a multiform transcriptional regulatory system,” International Review of Cytology, vol. 143, pp. 1–62, 1993. View at Google Scholar · View at Scopus
  38. T. H. Leung, A. Hoffmann, and D. Baltimore, “One nucleotide in a κB site can determine cofactor specificity for NF-κB dimers,” Cell, vol. 118, no. 4, pp. 453–464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Pizzi and P. Spano, “Distinct roles of diverse nuclear factor-κB complexes in neuropathological mechanisms,” European Journal of Pharmacology, vol. 545, no. 1, pp. 22–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. D. Jacobs and S. C. Harrison, “Structure of an IκBα/NF-κB complex,” Cell, vol. 95, no. 6, pp. 749–758, 1998. View at Google Scholar
  41. M. Karin and Y. Ben-Neriah, “Phosphorylation meets ubiquitination: the control of NF-κB activity,” Annual Review of Immunology, vol. 18, pp. 621–663, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Dejardin, “The alternative NF-κB pathway from biochemistry to biology: pitfalls and promises for future drug development,” Biochemical Pharmacology, vol. 72, no. 9, pp. 1161–1179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. N. D. Perkins, “Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway,” Oncogene, vol. 25, no. 51, pp. 6717–6730, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. L.-F. Chen, Y. Mu, and W. C. Greene, “Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB,” The EMBO Journal, vol. 21, no. 23, pp. 6539–6548, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Yeung, J. E. Hoberg, C. S. Ramsey et al., “Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase,” The EMBO Journal, vol. 23, no. 12, pp. 2369–2380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Lanzillotta, I. Sarnico, R. Ingrassia et al., “The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury,” Cell Death and Disease, vol. 1, no. 12, p. 1, 2010. View at Google Scholar
  47. S. Chiechio, A. Copani, L. De Petris, M. E. P. Morales, F. Nicoletti, and R. W. Gereau IV, “Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-κB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine,” Molecular Pain, vol. 2, article 20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Kaltschmidt, B. Kaltschmidt, and P. A. Baeuerle, “Brain synapses contain inducible forms of the transcription factor NF-κB,” Mechanisms of Development, vol. 43, no. 2-3, pp. 135–147, 1993. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Kaltschmidt, B. Kaltschmidt, H. Neumann, H. Wekerle, and P. A. Baeuerle, “Constitutive NF-κB activity in neurons,” Molecular and Cellular Biology, vol. 14, no. 6, pp. 3981–3992, 1994. View at Google Scholar · View at Scopus
  50. L. Guerrini, F. Blasi, and S. Denis-Donini, “Synaptic activation of NF-κB by glutamate in cerebellar granule neurons in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9077–9081, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. P. J. Meberg, W. R. Kinney, E. G. Valcourt, and A. Routtenberg, “Gene expression of the transcription factor NF-κB in hippocampus: regulation by synaptic activity,” Molecular Brain Research, vol. 38, no. 2, pp. 179–190, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Wellmann, B. Kaltschmidt, and C. Kaltschmidt, “Retrograde transport of transcription factor NF-κB in living neurons,” The Journal of Biological Chemistry, vol. 276, no. 15, pp. 11821–11829, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. M. K. Meffert, J. M. Chang, B. J. Wiltgen, M. S. Fanselow, and D. Baltimore, “NF-κB functions in synaptic signaling and behavior,” Nature Neuroscience, vol. 6, no. 10, pp. 1072–1078, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. M. N. Schölzke, I. Potrovita, S. Subramaniam, S. Prinz, and M. Schwaninger, “Glutamate activates NF-κB through calpain in neurons,” European Journal of Neuroscience, vol. 18, no. 12, pp. 3305–3310, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Suzuki, S. Mitake, K. Okumura-Noji, J.-P. Yang, T. Fujii, and T. Okamoto, “Presence of NF-κB-like and IκB-like immunoreactivities in postsynaptic densities,” NeuroReport, vol. 8, no. 13, pp. 2931–2935, 1997. View at Google Scholar · View at Scopus
  56. B. C. Albensi and M. P. Mattson, “Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity,” Synapse, vol. 35, no. 2, pp. 151–159, 2000. View at Google Scholar
  57. M. P. Mattson, C. Culmsee, Z. Yu, and S. Camandola, “Roles of nuclear factor κB in neuronal survival and plasticity,” Journal of Neurochemistry, vol. 74, no. 2, pp. 443–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. P. B. Burr and B. J. Morris, “Involvement of NMDA receptors and a p21Ras-like guanosine triphosphatase in the constitutive activation of nuclear factor-kappa-B in cortical neurons,” Experimental Brain Research, vol. 147, no. 3, pp. 273–279, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Lilienbaum and A. Israël, “From calcium to NF-κB signaling pathways in neurons,” Molecular and Cellular Biology, vol. 23, no. 8, pp. 2680–2698, 2003. View at Google Scholar
  60. R. Freudenthal, A. Romano, and A. Routtenberg, “Transcription factor NF-κB activation after in vivo perforant path LTP in mouse hippocampus,” Hippocampus, vol. 14, no. 6, pp. 677–683, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. S. B. Maggirwar, P. D. Sarmiere, S. Dewhurst, and R. S. Freeman, “Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons,” Journal of Neuroscience, vol. 18, no. 24, pp. 10356–10365, 1998. View at Google Scholar · View at Scopus
  62. A. D. Kovács, S. Chakraborty-Sett, S. H. Ramirez, L. F. Sniderhan, A. L. Williamson, and S. B. Maggirwar, “Mechanism of NF-κB inactivation induced by survival signal withdrawal in cerebellar granule neurons,” European Journal of Neuroscience, vol. 20, no. 2, pp. 345–352, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Grilli and M. Memo, “Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway,” Cell Death and Differentiation, vol. 6, no. 1, pp. 22–27, 1999. View at Google Scholar · View at Scopus
  64. J. Kucharczak, M. J. Simmons, Y. Fan, and C. Gélinas, “To be, or not to be: NF-κB is the answer—role of Rel/NF-κB in the regulation of apoptosis,” Oncogene, vol. 22, no. 56, pp. 8961–8982, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Gutierrez, V. A. Hale, X. Dolcet, and A. Davies, “NF-κB signalling regulates the growth of neural processes in the developing PNS and CNS,” Development, vol. 132, no. 7, pp. 1713–1726, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. N. Gavaldà, H. Gutierrez, and A. M. Davies, “Developmental switch in NF-κB signalling required for neurite growth,” Development, vol. 136, no. 20, pp. 3405–3412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. S. J. Russo, M. B. Wilkinson, M. S. Mazei-Robison et al., “Nuclear factor kB signaling regulates neuronal morphology and cocaine reward,” Journal of Neuroscience, vol. 29, no. 11, pp. 3529–3537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Gutierrez and A. M. Davies, “Regulation of neural process growth, elaboration and structural plasticity by NF-κB,” Trends in Neurosciences, vol. 34, no. 6, pp. 316–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. S. A. Bonini, G. Ferrari-Toninelli, D. Uberti et al., “Nuclear factor κb-dependent neurite remodeling is mediated by notch pathway,” Journal of Neuroscience, vol. 31, no. 32, pp. 11697–11705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Kaltschmidt, D. Ndiaye, M. Korte et al., “NF-κB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 2936–2946, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Boccia, R. Freudenthal, M. Blake et al., “Activation of hippocampal nuclear factor-κB by retrieval is required for memory reconsolidation,” Journal of Neuroscience, vol. 27, no. 49, pp. 13436–13445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. N. Federman, V. de la Fuente, G. Zalcman et al., “Nuclear factor κB-dependent histone acetylation is specifically involved in persistent form of memory,” The Journal of Neuroscience, vol. 33, no. 17, pp. 7603–7614, 2013. View at Publisher · View at Google Scholar
  73. S. Denis-Donini, A. Caprini, C. Frassoni, and M. Grilli, “Members of the NF-κB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain,” Developmental Brain Research, vol. 154, no. 1, pp. 81–89, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. D. Widera, I. Mikenberg, M. Elvers, C. Kaltschmidt, and B. Kaltschmidt, “Tumor necrosis factor α triggers proliferation of adult neural stem cells via IKK/NF-κB signaling,” BMC Neuroscience, vol. 7, article 64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Bernardino, F. Agasse, B. Silva, R. Ferreira, S. Grade, and J. O. Malva, “Tumor necrosis factor-α modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures,” Stem Cells, vol. 26, no. 9, pp. 2361–2371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Shingo, S. Todd Sorokan, T. Shimazaki, and S. Weiss, “Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells,” Journal of Neuroscience, vol. 21, no. 24, pp. 9733–9743, 2001. View at Google Scholar · View at Scopus
  77. T. Wada, J. J. Haigh, M. Ema et al., “Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival,” Journal of Neuroscience, vol. 26, no. 25, pp. 6803–6812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Y. Brazel, J. L. Nuñez, Z. Yang, and S. W. Levison, “Glutamate enhances survival and proliferation of neural progenitors derived from the subventricular zone,” Neuroscience, vol. 131, no. 1, pp. 55–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Rolls, R. Shechter, A. London et al., “Toll-like receptors modulate adult hippocampal neurogenesis,” Nature Cell Biology, vol. 9, no. 9, pp. 1081–1088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Widera, W. Holtkamp, F. Entschladen et al., “MCP-1 induces migration of adult neural stem cells,” European Journal of Cell Biology, vol. 83, no. 8, pp. 381–387, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. V. Meneghini, M. T. Francese, L. Carraro, and M. Grilli, “A novel role for the receptor for advanced glycation end-products in neural progenitor cells derived from adult subventricular zone,” Molecular and Cellular Neuroscience, vol. 45, no. 2, pp. 139–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. V. Meneghini, V. Bortolotto, M. T. Francese et al., “High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease,” The Journal of Neuroscience, vol. 33, no. 14, pp. 6047–6059, 2013. View at Google Scholar
  83. K. Takata, Y. Kitamura, J.-I. Kakimura et al., “Role of high mobility group protein-1 (HMG1) in amyloid-β homeostasis,” Biochemical and Biophysical Research Communications, vol. 301, no. 3, pp. 699–703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. J. H. Tam and S. H. Pasternak, “Amyloid and Alzheimer's disease: inside and out,” Canadian Journal of Neurological Sciences, vol. 39, no. 3, pp. 286–298, 2012. View at Google Scholar
  85. W. C. Sha, H.-C. Liou, E. I. Tuomanen, and D. Baltimore, “Targeted disruption of the p50 subunit of NF-κb leads to multifocal defects in immune responses,” Cell, vol. 80, no. 2, pp. 321–330, 1995. View at Google Scholar · View at Scopus
  86. S. Denis-Donini, A. Dellarole, P. Crociara et al., “Impaired adult neurogenesis associated with short-term memory defects in NF-κB p50-deficient mice,” Journal of Neuroscience, vol. 28, no. 15, pp. 3911–3919, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. K. Oikawa, G. L. Odero, E. Platt et al., “NF-kappaB p50 subunit knockout impairs late LTP and alters long term memory in the mouse hippocampus,” BMC Neuroscience, vol. 13, p. 45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. F. D. Lubin and J. D. Sweatt, “The IκB kinase regulates chromatin structure during reconsolidation of conditioned fear memories,” Neuron, vol. 55, no. 6, pp. 942–957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. M. K. Meffert and D. Baltimore, “Physiological functions for brain NF-κB,” Trends in Neurosciences, vol. 28, no. 1, pp. 37–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. J. M. Levenson, S. Choi, S.-Y. Lee et al., “A Bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel,” Journal of Neuroscience, vol. 24, no. 16, pp. 3933–3943, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Imielski, J. C. Schwamborn, P. Lüningschrör et al., “Regrowing the adult brain: NF-κB controls functional circuit formation and tissue homeostasis in the dentate gyrus,” PLoS ONE, vol. 7, no. 2, Article ID e30838, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Maqbool, M. Lattke, T. Wirth, and B. Baumann, “Sustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging,” Molecular Neurodegeneration, vol. 8, no. 1, p. 40, 2013. View at Google Scholar
  93. Y. Zhang, J. Liu, S. Yao et al., “Nuclear factor kappa B signaling initiates early differentiation of neural stem cells,” Stem Cells, vol. 30, no. 3, pp. 510–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Brambilla, V. Bracchi-Ricard, W.-H. Hu et al., “Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 145–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. M. V. Kokoeva, H. Yin, and J. S. Flier, “Neurogenesis in the hypothalamus of adult mice: potential role in energy balance,” Science, vol. 310, no. 5748, pp. 679–683, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. A. A. Pierce and A. W. Xu, “De novo neurogenesis in adult hypothalamus as a compensatory mechanism to regulate energy balance,” Journal of Neuroscience, vol. 30, no. 2, pp. 723–730, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai, “Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity,” Cell, vol. 135, no. 1, pp. 61–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Purkayastha, G. Zhang, and D. Cai, “Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB,” Nature Medicine, vol. 17, no. 7, pp. 883–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. J. Li, Y. Tang, and D. Cai, “IKKβ/NF-κB disrupt adult hypothalamic neural stem cells to mediate neurodegenerative mechanism of dietary obesity and pre-diabetes,” Nature Cell Biology, vol. 14, no. 10, pp. 999–1012, 2012. View at Google Scholar
  100. W. Deng, J. B. Aimone, and F. H. Gage, “New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?” Nature Reviews Neuroscience, vol. 11, no. 5, pp. 339–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. J. B. Aimone, W. Deng, and F. H. Gage, “Resolving new memories: a critical look at the dentate gyrus, adult neurogenesis, and pattern separation,” Neuron, vol. 70, no. 4, pp. 589–596, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Couillard-Despres, R. Vreys, L. Aigner, and A. Van der Linden, “In vivo monitoring of adult neurogenesis in health and disease,” Frontiers in Neuroscience, vol. 5, p. 67, 2011. View at Google Scholar
  103. A. Sahay, K. N. Scobie, A. S. Hill et al., “Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation,” Nature, vol. 472, no. 7344, pp. 466–470, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. B. A. Samuels and R. Hen, “Neurogenesis and affective disorders,” European Journal of Neuroscience, vol. 33, no. 6, pp. 1152–1159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. O. Lazarov and R. A. Marr, “Neurogenesis and Alzheimer's disease: at the crossroads,” Experimental Neurology, vol. 223, no. 2, pp. 267–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. J. E. Malberg and J. A. Blendy, “Antidepressant action: to the nucleus and beyond,” Trends in Pharmacological Sciences, vol. 26, no. 12, pp. 631–638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. C. Pittenger and R. S. Duman, “Stress, depression, and neuroplasticity: a convergence of mechanisms,” Neuropsychopharmacology, vol. 33, no. 1, pp. 88–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. N. D. Hanson, M. J. Owens, and C. B. Nemeroff, “Depression, antidepressants, and neurogenesis: a critical reappraisal,” Neuropsychopharmacology, vol. 36, no. 13, pp. 2589–2602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. J. E. Malberg, A. J. Eisch, E. J. Nestler, and R. S. Duman, “Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus,” Journal of Neuroscience, vol. 20, no. 24, pp. 9104–9110, 2000. View at Google Scholar · View at Scopus
  110. L. Santarelli, M. Saxe, C. Gross et al., “Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants,” Science, vol. 301, no. 5634, pp. 805–809, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. R. S. Duman, G. R. Heninger, and E. J. Nestler, “A molecular and cellular theory of depression,” Archives of General Psychiatry, vol. 54, no. 7, pp. 597–606, 1997. View at Google Scholar · View at Scopus
  112. G. Griebel, J. Simiand, R. Steinberg et al., “4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1- (3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor1 receptor antagonist. II. Characterization in rodent models of stress-related disorders,” Journal of Pharmacology and Experimental Therapeutics, vol. 301, no. 1, pp. 333–345, 2002. View at Publisher · View at Google Scholar · View at Scopus
  113. G. Griebel, J. Simiand, C. Serradeil-Le Gal et al., “Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 9, pp. 6370–6375, 2002. View at Publisher · View at Google Scholar · View at Scopus
  114. R. Alonso, G. Griebel, G. Pavone, J. Stemmelin, G. Le Fur, and P. Soubrié, “Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression,” Molecular Psychiatry, vol. 9, no. 3, pp. 278–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Banasr, A. Soumier, M. Hery, E. Mocaër, and A. Daszuta, “Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis,” Biological Psychiatry, vol. 59, no. 11, pp. 1087–1096, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Morley-Fletcher, J. Mairesse, A. Soumier et al., “Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats,” Psychopharmacology, vol. 217, no. 3, pp. 301–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. D. J. David, B. A. Samuels, Q. Rainer et al., “Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression,” Neuron, vol. 62, no. 4, pp. 479–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. M. Boldrini, M. D. Underwood, R. Hen et al., “Antidepressants increase neural progenitor cells in the human hippocampus,” Neuropsychopharmacology, vol. 34, no. 11, pp. 2376–2389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. G. J. Sills, “The mechanisms of action of gabapentin and pregabalin,” Current Opinion in Pharmacology, vol. 6, no. 1, pp. 108–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. C. P. Taylor, T. Angelotti, and E. Fauman, “Pharmacology and mechanism of action of pregabalin: the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery,” Epilepsy Research, vol. 73, no. 2, pp. 137–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. M. J. Field, P. J. Cox, E. Stott et al., “Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17537–17542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. S. M. Lotarski, S. Donevan, A. El-Kattan et al., “Anxiolytic-like activity of pregabalin in the vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants,” Journal of Pharmacology and Experimental Therapeutics, vol. 338, no. 2, pp. 615–621, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. C.-U. Pae, “Pregabalin augmentation to antidepressants in patients with major depressive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 3, pp. 577–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. D. J. Stein, D. S. Baldwin, F. Baldinetti, and F. Mandel, “Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies,” European Neuropsychopharmacology, vol. 18, no. 6, pp. 422–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. M. M. Valente, V. Bortolotto, B. Cuccurazzu et al., “α2δ ligands act as positive modulators of adult hippocampal neurogenesis and prevent depression-like behavior induced by chronic restraint stress,” Molecular Pharmacology, vol. 82, no. 2, pp. 271–280, 2012. View at Google Scholar
  126. H. N. Bockbrader, L. L. Radulovic, E. L. Posvar et al., “Clinical pharmacokinetics of pregabalin in healthy volunteers,” Journal of Clinical Pharmacology, vol. 50, no. 8, pp. 941–950, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. J. W. Pettegrew, J. Levine, and R. J. McClure, “Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: Relevance for its mode of action in Alzheimer's disease and geriatric depression,” Molecular Psychiatry, vol. 5, no. 6, pp. 616–632, 2000. View at Google Scholar · View at Scopus
  128. A. Inano, Y. Sai, H. Nikaido et al., “Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2,” Biopharmaceutics and Drug Disposition, vol. 24, no. 8, pp. 357–365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. L. L. Jones, D. A. McDonald, and P. R. Borum, “Acylcarnitines: role in brain,” Progress in Lipid Research, vol. 49, no. 1, pp. 61–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Chiechio, M. Zammataro, M. E. Morales et al., “Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain,” Molecular Pharmacology, vol. 75, no. 5, pp. 1014–1020, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. E. Tempesta, L. Casella, and C. Pirrongelli, “L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo,” Drugs under Experimental and Clinical Research, vol. 13, no. 7, pp. 417–423, 1987. View at Google Scholar · View at Scopus
  132. G. Garzya, D. Corallo, A. Fiore, G. Lecciso, G. Petrelli, and C. Zotti, “Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression,” Drugs under Experimental and Clinical Research, vol. 16, no. 2, pp. 101–106, 1990. View at Google Scholar · View at Scopus
  133. R. Bella, R. Biondi, R. Raffaele, and G. Pennisi, “Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders,” International Journal of Clinical Pharmacology Research, vol. 10, no. 6, pp. 355–360, 1990. View at Google Scholar · View at Scopus
  134. R. Zanardi and E. Smeraldi, “A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia,” European Neuropsychopharmacology, vol. 16, no. 4, pp. 281–287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. B. Cuccurazzu, V. Bortolotto, M. M. Valente et al., “Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-l-carnitine,” Neuropsychopharmacology, vol. 38, no. 11, pp. 2220–2230, 2013. View at Google Scholar
  136. C. Nasca, D. Xenos, Y. Barone et al., “L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 12, pp. 4804–4809, 2013. View at Google Scholar
  137. D. H. Overstreet and G. Wegener, “The flinder sensitive line rat model of depression—25 years and still producing,” Pharmacological Reviews, vol. 65, no. 1, pp. 143–155, 2013. View at Google Scholar
  138. W. K. Ja and R. S. Duman, “IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 2, pp. 751–756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Grilli and M. Memo, “Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity?” Molecular Psychiatry, vol. 2, no. 3, pp. 192–194, 1997. View at Google Scholar · View at Scopus